Investors Research Corp Teva Pharmaceutical Industries LTD Transaction History

Investors Research Corp

  • $523 Million
  • Q4 2025

A detailed history of Investors Research Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Investors Research Corp holds 13,274 shares of TEVA stock, worth $337,292. This represents 0.06% of its overall portfolio holdings.

Number of Shares
13,274
Previous 23,891 44.44%
Holding current value
$337,292
Previous $482,000 30.08%
% of portfolio
0.06%
Previous 0.09%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 06, 2026
SELL
$18.95 - $25.83 $201,192 - $274,237
-10,617 Reduced 44.44%
13,274 $337,000
Q4 2024

Feb 07, 2025
SELL
$16.43 - $22.77 $4,929 - $6,831
-300 Reduced 1.24%
23,891 $526,000
Q2 2024

Jul 31, 2024
SELL
$12.78 - $17.4 $4,792 - $6,524
-375 Reduced 1.53%
24,191 $393,000
Q1 2024

May 06, 2024
SELL
$10.67 - $14.43 $9,069 - $12,265
-850 Reduced 3.34%
24,566 $346,000
Q2 2023

Aug 14, 2023
SELL
$7.2 - $9.47 $1,440 - $1,894
-200 Reduced 0.78%
25,416 $191,000
Q1 2023

May 11, 2023
SELL
$8.36 - $11.37 $1,880 - $2,558
-225 Reduced 0.87%
25,616 $226,000
Q4 2022

Feb 06, 2023
SELL
$7.95 - $9.48 $1,788 - $2,133
-225 Reduced 0.86%
25,841 $235,000
Q2 2022

Jul 21, 2022
SELL
$7.38 - $10.4 $2,214 - $3,120
-300 Reduced 1.14%
26,066 $196,000
Q4 2021

Jan 27, 2022
SELL
$7.9 - $10.19 $2,765 - $3,566
-350 Reduced 1.31%
26,366 $211,000
Q1 2021

Apr 28, 2021
SELL
$10.34 - $12.81 $775 - $960
-75 Reduced 0.28%
26,716 $308,000
Q4 2020

Jan 21, 2021
SELL
$8.61 - $11.04 $10,762 - $13,799
-1,250 Reduced 4.46%
26,791 $259,000
Q3 2020

Oct 20, 2020
SELL
$8.57 - $12.69 $2,142 - $3,172
-250 Reduced 0.88%
28,041 $253,000
Q2 2020

Jul 21, 2020
SELL
$8.12 - $13.12 $6,292 - $10,168
-775 Reduced 2.67%
28,291 $349,000
Q1 2020

May 05, 2020
SELL
$6.69 - $13.45 $1,672 - $3,362
-250 Reduced 0.85%
29,066 $261,000
Q4 2019

Feb 11, 2020
SELL
$6.53 - $10.72 $1,632 - $2,680
-250 Reduced 0.85%
29,316 $287,000
Q3 2019

Oct 22, 2019
SELL
$6.16 - $9.6 $154 - $240
-25 Reduced 0.08%
29,566 $203,000
Q2 2019

Jul 08, 2019
SELL
$8.12 - $15.72 $3,450 - $6,681
-425 Reduced 1.42%
29,591 $273,000
Q1 2019

Apr 23, 2019
SELL
$15.58 - $20.01 $4,674 - $6,003
-300 Reduced 0.99%
30,016 $471,000
Q4 2018

Feb 04, 2019
BUY
$14.59 - $23.84 $3,647 - $5,960
250 Added 0.83%
30,316 $467,000
Q3 2018

Nov 14, 2018
SELL
$21.06 - $25.65 $11,604 - $14,133
-551 Reduced 1.8%
30,066 $648,000
Q2 2018

Aug 10, 2018
BUY
$16.77 - $24.71 $7,965 - $11,737
475 Added 1.58%
30,617 $745,000
Q1 2018

May 09, 2018
SELL
$16.68 - $22.07 $11,676 - $15,449
-700 Reduced 2.27%
30,142 $515,000
Q4 2017

Feb 13, 2018
BUY
$11.23 - $19.1 $346,355 - $589,082
30,842
30,842 $584,000

Others Institutions Holding TEVA

# of Institutions
669
Shares Held
624M
Call Options Held
30.8M
Put Options Held
18.5M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $28.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Investors Research Corp Portfolio

Follow Investors Research Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

News

Stay updated on Investors Research Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email